These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30927733)
1. Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis. Edwards KR; Garten L; Button J; O'Connor J; Kamath V; Frazier C Mult Scler Relat Disord; 2019 Jun; 31():59-61. PubMed ID: 30927733 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies. Martin SJ; McGlasson S; Hunt D; Overell J J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141 [TBL] [Abstract][Full Text] [Related]
3. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770 [TBL] [Abstract][Full Text] [Related]
4. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. Lycke JN; Karlsson JE; Andersen O; Rosengren LE J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):402-4. PubMed ID: 9527161 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of CSF neurofilament light and heavy chain protein in MS. Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999 [TBL] [Abstract][Full Text] [Related]
6. Neurofilaments and 10-year follow-up in multiple sclerosis. Bhan A; Jacobsen C; Myhr KM; Dalen I; Lode K; Farbu E Mult Scler; 2018 Sep; 24(10):1301-1307. PubMed ID: 30066611 [TBL] [Abstract][Full Text] [Related]